Credit Suisse’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $219M | Sell |
422,240
-11,742
| -3% | -$5.84M | 0.21% | 86 |
|
|
2023
Q4 | $205M | Buy |
433,982
+13,755
| +3% | +$6.36M | 0.2% | 91 |
|
|
2023
Q3 | $183M | Sell |
420,227
-85,244
| -17% | -$38.7M | 0.19% | 98 |
|
|
2023
Q2 | $225M | Sell |
505,471
-30,948
| -6% | -$14.3M | 0.22% | 84 |
|
|
2023
Q1 | $247M | Buy |
536,419
+38,524
| +8% | +$18.3M | 0.25% | 70 |
|
|
2022
Q4 | $255M | Buy |
497,895
+54,846
| +12% | +$27.8M | 0.27% | 68 |
|
|
2022
Q3 | $201M | Sell |
443,049
-988
| -0.2% | -$473K | 0.22% | 82 |
|
|
2022
Q2 | $214M | Buy |
444,037
+156,282
| +54% | +$77.3M | 0.22% | 77 |
|
|
2022
Q1 | $141M | Buy |
287,755
+18,520
| +7% | +$8.47M | 0.12% | 170 |
|
|
2021
Q4 | $125M | Sell |
269,235
-22,135
| -8% | -$9.31M | 0.07% | 306 |
|
|
2021
Q3 | $109M | Sell |
291,370
-21,886
| -7% | -$8.32M | 0.06% | 345 |
|
|
2021
Q2 | $120M | Sell |
313,256
-4,809
| -2% | -$1.84M | 0.06% | 326 |
|
|
2021
Q1 | $114M | Sell |
318,065
-27,643
| -8% | -$8.89M | 0.06% | 361 |
|
|
2020
Q4 | $111M | Sell |
345,708
-30,121
| -8% | -$9.24M | 0.05% | 377 |
|
|
2020
Q3 | $101M | Sell |
375,829
-8,630
| -2% | -$2.32M | 0.06% | 341 |
|
|
2020
Q2 | $101M | Sell |
384,459
-13,086
| -3% | -$3.49M | 0.07% | 277 |
|
|
2020
Q1 | $90.3M | Sell |
397,545
-50,553
| -11% | -$13.8M | 0.08% | 249 |
|
|
2019
Q4 | $135M | Buy |
448,098
+46,969
| +12% | +$12.9M | 0.1% | 201 |
|
|
2019
Q3 | $96.3M | Buy |
401,129
+25,613
| +7% | +$7.02M | 0.08% | 235 |
|
|
2019
Q2 | $106M | Buy |
375,516
+14,150
| +4% | +$3.87M | 0.09% | 211 |
|
|
2019
Q1 | $104M | Sell |
361,366
-99,738
| -22% | -$28.8M | 0.09% | 211 |
|
|
2018
Q4 | $121M | Buy |
461,104
+77,890
| +20% | +$21.4M | 0.13% | 152 |
|
|
2018
Q3 | $105M | Buy |
383,214
+28,085
| +8% | +$7.29M | 0.09% | 205 |
|
|
2018
Q2 | $84.5M | Sell |
355,129
-112,785
| -24% | -$26.1M | 0.08% | 225 |
|
|
2018
Q1 | $103M | Buy |
467,914
+5,368
| +1% | +$1.26M | 0.1% | 201 |
|
|
2017
Q4 | $104M | Buy |
462,546
+94,754
| +26% | +$20.2M | 0.09% | 210 |
|
|
2017
Q3 | $69.8M | Sell |
367,792
-37,773
| -9% | -$7.19M | 0.07% | 310 |
|
|
2017
Q2 | $76.3M | Sell |
405,565
-103,164
| -20% | -$18.5M | 0.07% | 253 |
|
|
2017
Q1 | $84.1M | Sell |
508,729
-55,539
| -10% | -$8.83M | 0.08% | 256 |
|
|
2016
Q4 | $81.1M | Buy |
564,268
+85,670
| +18% | +$11.5M | 0.08% | 254 |
|
|
2016
Q3 | $60M | Sell |
478,598
-4,160
| -0.9% | -$537K | 0.06% | 363 |
|
|
2016
Q2 | $63.4M | Buy |
482,758
+38,113
| +9% | +$5.21M | 0.07% | 278 |
|
|
2016
Q1 | $61.8M | Buy |
444,645
+38,684
| +10% | +$5.17M | 0.07% | 274 |
|
|
2015
Q4 | $56.6M | Buy |
405,961
+13,384
| +3% | +$1.84M | 0.07% | 326 |
|
|
2015
Q3 | $55M | Buy |
392,577
+149,499
| +62% | +$22.5M | 0.07% | 330 |
|
|
2015
Q2 | $39.9M | Buy |
+243,078
| New | +$38.8M | 0.04% | 523 |
|
|
2015
Q1 | – | Sell |
-687,499
| Closed | -$86.4M | – | 4405 |
|
|
2014
Q4 | $86.4M | Sell |
687,499
-29,896
| -4% | -$3.69M | 0.08% | 265 |
|
|
2014
Q3 | $85.8M | Sell |
717,395
-6,343
| -0.9% | -$728K | 0.07% | 286 |
|
|
2014
Q2 | $77.9M | Buy |
723,738
+19,904
| +3% | +$2.05M | 0.06% | 305 |
|
|
2014
Q1 | $70.1M | Sell |
703,834
-2,015,678
| -74% | -$182M | 0.07% | 290 |
|
|
2013
Q4 | $251M | Buy |
2,719,512
+2,148,084
| +376% | +$191M | 0.23% | 75 |
|
|
2013
Q3 | $47.8M | Sell |
571,428
-83,448
| -13% | -$7.15M | 0.05% | 363 |
|
|
2013
Q2 | $53.6M | Buy |
+654,876
| New | +$49M | 0.05% | 356 |
|
Other funds holding ELV
Credit Suisse's ELV Position: Q1 2024 in Review
Credit Suisse reduced its Elevance Health (ELV) stake by 2.7% in Q1 2024, selling an estimated $5.84M and leaving 422,240 shares worth $219M. The position accounts for 0.21% of the portfolio, ranked #86.
Credit Suisse first reported a position in ELV in Q2 2013 and has held it in 43 quarters since. The position peaked at $255M in Q4 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Credit Suisse held 422,240 shares of Elevance Health worth $219M as of Q1 2024.
- Credit Suisse sold 11,742 Elevance Health shares in Q1 2024, an estimated $5.84M.
- Elevance Health made up 0.21% of Credit Suisse's portfolio in Q1 2024, its #86 holding.
- Credit Suisse first reported a position in Elevance Health in Q2 2013 and has held it in 43 quarters since.
- Credit Suisse's Elevance Health position peaked at $255M in Q4 2022.
- 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.